EGLN2 and ovarian carcinoma: Collectively, these results suggest that 20(S)-Rg3 blocked hypoxia-induced EMT of the ovarian cancer cells by activating the PHD1- VHL- ubiquitin/proteasome pathway to facilitate HIF-1α degradation.